iiia
Entity, reached from Hormuz.
- Evidence
- 23 documents · 10 separate publishers
- Standing
- Added automatically from coverage
- Time
- first seen 4 Sept 2026, last seen 7 Oct 2026
- Measured
- 39% of mentions say something specific about it; the rest only name it
- As of
- 10 Oct 2026
Where this comes from
- Denkstrom · 2026-10-07 · FDA erlaubt Fayuvi für MPS-IIIA-Kinder mit erhaltener Neuroentwicklung (opens the source in a new tab)
- GEN · 2026-09-22 · Andelyn Curator Biomanufacturing Platform Supports Fayuvi Gene Therapy Approval (opens the source in a new tab)
- FDA · 2026-09-18 · FDA Approves First Gene Therapy for Pediatric Patients with Sanfilippo Syndrome Type A (opens the source in a new tab)
- Cancers (Basel) · 2026-09-04 · HistoNav: AI-Based H&E Histopathology Predicts Disease-Specific Survival and Guides Adjuvant Chemotherapy Decisions in Stage II/IIIA Colorectal Cancer. (opens the source in a new tab)
What is claimed about it
Situations it is named in
Who it moves with
- co-mentioned with lung cancer (13 documents)seen together
- co-mentioned with egfr (12 documents)seen together
- co-mentioned with egfr-mutated (11 documents)seen together
- co-mentioned with her2 (11 documents)seen together
- co-mentioned with cancer center (10 documents)seen together
- co-mentioned with her2-directed (9 documents)seen together
- co-mentioned with herbst (9 documents)seen together
- co-mentioned with iaslc (9 documents)seen together
- co-mentioned with ros1-positive (9 documents)seen together
- co-mentioned with her2-mutant (8 documents)seen together